- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06466109
Using Social Robots in Children With Rare Diseases and Their Parents: A Feasibility Study
Using Social Robots to Improve the Relationship and Alleviate Anxiety and Stress in Children With Rare Diseases and Their Parents: A Feasibility Study
The goals of this clinical trial are to (a) evaluate the feasibility and acceptability of a social robot intervention for providing family-based care for rare diseases families and (b) explore the effectiveness of the social robot intervention in improving the parent-child relationships and alleviating stress and anxiety for rare diseases patients and their parents. The main questions are:
- Is the social robot intervention suitable for and acceptable to rare disease patients and parents?
- Does the social robot intervention improve the parent-child relationship of rare disease patients and their parents?
- Does the social robot intervention alleviate the stress and anxiety of rare disease patients and their parents? Patients and their parents will interact with the social robot PARO separately and together in each 30-minute course every two weeks for four courses.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 11217
- Taipei Veterans General Hospital
-
Taipei, Taiwan, 100226
- National Taiwan University Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
[Patients]
- Aged 8 to 19 years.
- Diagnosed with a rare disease.
- Be Able to communicate in Chinese. [Parents]
- A father or a mother of a child with a rare disease.
- Be Able to communicate in Chinese.
Exclusion Criteria:
[Patients]
- Have a pacemaker.
- Have open wounds.
- Being infected with infectious diseases.
- Be unable to participate in social activities due to severe psychological disorder or cognitive dysfunction.
[Parents]
- Have a pacemaker.
- Have open wounds.
- Being infected with infectious diseases.
- Be unable to participate in social activities due to severe psychological disorder or cognitive dysfunction.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
Patients and their parents will interact with the social robot PARO separately and together in each 30-minute course every two weeks for four courses.
|
In the first and second courses, the patients and their parents freely interact with the social robot PARO for 30 minutes. In the third course, patients and their parents interact with PARO for 30 minutes using a worksheet that includes naming and recording characteristics of PARO. In the last course, patients and their parents interact with PARO for 30 minutes using a worksheet that freely recorded their observations about PARO and say goodbye to it. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
retention rate
Time Frame: immediately after the intervention
|
The retention rate is the average percentage of the patient-parent dyads who complete the 4-course intervention.
|
immediately after the intervention
|
|
acceptability
Time Frame: immediately after the intervention
|
The unified theory of acceptance and use of technology (UTAUT) scale will measure participants' acceptability of the social robot intervention.
The chosen domains of this scale are perceived sociability (4 items), social presence (5 items), and perceived enjoyment (5 items) due to the importance of social robot interaction and sociability.
Each item is assessed on a 5-point Likert scale, varying from 1 to 5; each domain's score is summed up individually; higher scores represent more agreement with this domain.
|
immediately after the intervention
|
|
parent-child relationship
Time Frame: immediately after the intervention
|
The elementary school student parent-child relationship scale will measure the patient's perceived parent-child relationship. The scale is composed of a 25-item questionnaire. Each item is assessed on a 5-point Likert scale, varying from 1 to 5, with total points ranging from 25 to 125, with higher scores representing better parent-child relationships. As for the parent's perceived parent-child relationship, the researcher modified part of the elementary school student parent-child relationship scale, and a psychological specialist validated the content. The score calculation is similar to the elementary school student parent-child relationship scale. |
immediately after the intervention
|
|
anxiety
Time Frame: immediately after the intervention
|
The Chinese Version of the State Anxiety Scale for Children will measure the patient's anxiety. The scale is composed of a 20-item questionnaire. Each item is assessed on a 3-point Likert scale, varying from 1 to 3, with total points ranging from 20 to 60, with higher scores representing higher anxiety. The State-Trait Anxiety Inventory-State Anxiety will measure the parent's anxiety. The scale is composed of a 20-item questionnaire. Each item is assessed on a 4-point Likert scale, varying from 1 to 4, with total points ranging from 20 to 80, with higher scores representing higher anxiety. |
immediately after the intervention
|
|
stress
Time Frame: immediately after the intervention
|
The heart rate variability and the Perceived Stress Scale will measure the patient's and the parent's stress. The researcher uses " Taiwan Scientific" Non-invasive Blood Pressure Meter to measure the heart rate variability, recording the low frequency power (LF), high frequency power (HF), and the ratio LF (ms2)/HF (ms2). The Perceived Stress Scale is composed of a 10-item questionnaire. Each item is assessed on a 5-point Likert scale, varying from 0 to 4, with total points ranging from 0 to 40, with higher scores representing higher perceived stress. |
immediately after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
child-parent-robot interaction
Time Frame: immediately after the intervention
|
A self-designed questionnaire and an interview framework are used to explore the child-parent-robot interaction and the effectiveness of the social robot intervention in the patients and the parents individually.
The 6-item questionnaire is assessed on a Visual Analogue Scale, ranging from 0 to 10.
A higher score for each item represents being more engaged in the interaction with PARO, enjoying this intervention more, or being more willing to talk about the study with each other at home.
The interview framework has six open-ended questions to delve into the patient's and the parent's experiences of the intervention.
|
immediately after the intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-05-005B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rare Diseases
-
Seoul National University HospitalRecruitingGenetic Rare DiseaseKorea, Republic of
-
Centre Hospitalier Universitaire DijonRecruitingNewborn Screening Programmes for Rare DiseasesFrance
-
Scripps Translational Science InstituteEnrolling by invitation
-
University Hospital, Strasbourg, FranceRecruiting
-
Shandong UniversityNational Health Medical Data (North Center)Recruiting
-
BioMarin PharmaceuticalUnknownRare Genetic DisordersUnited States
-
Wuerzburg University HospitalHannover Medical School; Goethe University; University Hospital Tuebingen; Universitätsklinikum... and other collaboratorsCompletedRare Diseases | Orphan DiseasesGermany
-
Sanguine BiosciencesRecruiting
-
Swedish Orphan BiovitrumCompleted
-
Illumina, Inc.Children's Hospital of Philadelphia; St. Louis Children's Hospital; Children's... and other collaboratorsCompleted
Clinical Trials on social robot intervention
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Turin, Italy; Politecnico di MilanoRecruitingAutism Spectrum DisorderItaly
-
Education University of Hong KongRecruitingAutism Spectrum Disorder | Social Engagement | Robotic InterventionHong Kong
-
Ondokuz Mayıs UniversityCompletedFear | Wound Care | Fear Anxiety | Distraction | Distraction Methods | Children Pain ManagementTurkey (Türkiye)
-
DreamFace Technologies, LLCCompletedAlzheimer Disease, Early OnsetUnited States
-
Gérond'ifRecruitingElderly People Living at Home | With an Internet Connection at HomeFrance
-
Samsung Medical CenterCompletedPediatricsKorea, Republic of
-
Ben-Gurion University of the NegevCompleted
-
The Hong Kong Polytechnic UniversityCompletedDepression | Cognitive Impairment | Loneliness | Self Efficacy | Sense of CoherenceHong Kong